Abdelmoneim Ahmed S, Miller Lisa M, Armstrong Sean, Sood Manish M, Wazny Lori, Chateau Dan, Vercaigne Lavern M
Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Hemodial Int. 2012 Apr;16(2):298-305. doi: 10.1111/j.1542-4758.2011.00609.x.
Hemodialysis (HD) catheter dysfunction compromises HD adequacy and increases the cost of patient care. Repeated administration of alteplase in HD catheters typically produces only short-term benefits. The purpose of this study was to design, implement, and evaluate the efficacy of an experimental alteplase algorithm to manage HD catheter dysfunction. This was a two-part prospective nonrandomized study. Baseline data of alteplase use and catheter exchange were collected during part 1 of the study. Part 2 consisted of the alteplase algorithm implementation and repeat collection of catheter data. Rates of alteplase use and catheter exchange per 1000 catheter-days were the primary and secondary outcomes of the study. One hundred and seventy-two catheters in 131 patients were followed prospectively during the course of the study. The adjusted relative rate (RR) of alteplase use showed no significant difference between both parts of the study, adjusted RR: 1.10, 95% confidence interval (CI) (0.73-1.65). Similarly, catheter exchange rates were not significantly different over the duration of the study (1.12 vs. 1.03 per 1000 catheter-days). However, waiting time for catheter exchange increased from 20.36 ± 14 days in part 1 to 38.42 ± 28 days in part 2 (P < 0.05). The alteplase algorithm did not significantly reduce alteplase use. This may be partially explained by repeated use of alteplase in part 2, due to longer waiting times for catheter exchange procedures.
血液透析(HD)导管功能障碍会影响血液透析的充分性,并增加患者护理成本。在HD导管中反复使用阿替普酶通常仅产生短期益处。本研究的目的是设计、实施并评估一种用于处理HD导管功能障碍的实验性阿替普酶算法的疗效。这是一项分为两部分的前瞻性非随机研究。在研究的第1部分收集了阿替普酶使用和导管更换的基线数据。第2部分包括阿替普酶算法的实施以及导管数据的重复收集。每1000导管日的阿替普酶使用和导管更换率是该研究的主要和次要结果。在研究过程中对131例患者的172根导管进行了前瞻性随访。阿替普酶使用的调整相对率(RR)在研究的两部分之间无显著差异,调整RR:1.10,95%置信区间(CI)(0.73 - 1.65)。同样,在研究期间导管更换率也无显著差异(每1000导管日分别为1.12和1.03)。然而,导管更换的等待时间从第1部分的20.36±14天增加到第2部分的38.42±28天(P < 0.05)。阿替普酶算法并未显著减少阿替普酶的使用。这可能部分是由于在第2部分中因导管更换程序的等待时间更长而反复使用阿替普酶所致。